← Back to NDRA

ENDRA Life Sciences Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/08/2025Mar 2024Filed 15/05/2025
$0.2−$1.3−$1.6−$1.2−$1−$2.4−$2.2−$2.8
$0.06−$1.09−$2.10−$1.71−$1.86−$9.54
2.51.20.80.70.60.2

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.